Radboud University Medical Center: Cardiovascular Diseases trials

The registry lists 26 Cardiovascular Diseases studies with Radboud University Medical Center as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 2Phase 4 6No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Physical Activity Programme Focussed on Step Volume and Intensity for People With Cardiovascular Disease: Getting Active and Staying Active After Cardiac RehabilitationNot yet recruitingNCT07723274Not applicable
• Observational Dutch Young Symptomatic StrokE studY - nEXTRecruitingNCT05853796
• High-fat Challenge Induced Trained Innate Immunity (SHAKE Study)CompletedNCT05682456Not applicable
• Time Restricted Eating and Innate ImmunityCompletedNCT05639244Not applicable
• Physical Activity Levels and Statin TherapyCompletedNCT05625945
• Colchicine and Inflammation in Aortic StenosisActive, not recruitingNCT05162742Phase 3
• Exercise-induced Muscle Damage in Statin UsersCompletedNCT05011643
• Activation Innate Immune System in Type 1 DiabetesCompletedNCT03441919
• Blood Pressure After PREeclampsia/HELLP by SELF Monitoring StudyCompletedNCT03228082Not applicable
• The Role of Stem Cells on Immune Cells in the Development of Cardiovascular DiseasesCompletedNCT03172507
• Interruption of TNFinhibitors and Endothelial FunctionStatus unknownNCT02130076
• Exercise Test and Cardiac InjuryCompletedNCT01660828Not applicable
• The Impact of Age and Fitness on Reperfusion Injury and Ischemic Preconditioning to Prevent This InjuryCompletedNCT01606410
• Evaluation of Non-invasive Measurements of Atherosclerosis in Cardiovascular Risk StratificationCompletedNCT01555294
• Intervention to Improve Medication Adherence in Cardiovascular PatientsCompletedNCT01449695Not applicable
• The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) TrialCompletedNCT01438723Phase 4
• Effects of Exercise Training and AGE-crosslink Breaker on Cardiovascular Structure and FunctionCompletedNCT01417663Phase 2/3
• Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?CompletedNCT01295567Phase 4
• Interaction in Chronic Obstructive Pulmonary Disease ExperimentCompletedNCT00981851Not applicable
• Heme Oxygenase (HO) Activity and Adenosine Induced VasodilationTerminatedNCT00856817Phase 4
• Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?CompletedNCT00851175Phase 4
• Evaluation Research of a National Accreditation and Improvement Programme for General PracticeCompletedNCT00791362Not applicable
• Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering DrugsCompletedNCT00509717Not applicable
• Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm ExerciseWithdrawnNCT00441714Not applicable
• Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?CompletedNCT00441597Phase 4
• Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?CompletedNCT00430170Phase 4